A1Z Pharmaceuticals

A1Z Pharmaceuticals is a London-based biotechnology company dedicated to discovering treatments for neurodegenerative diseases using a proprietary artificial intelligence platform. The company focuses on identifying novel drug targets and repurposing existing molecules for conditions such as Alzheimer's and Parkinson's disease. By integrating multi-omic data with clinical outcomes, A1Z aims to decode the complex biology of the aging brain and protein misfolding. Their approach emphasizes precision medicine to address the significant unmet needs in neurology and age-related decline. A1Z operates as a discovery-stage entity, leveraging computational insights to build a pipeline of small molecule therapeutics.